We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Loop Industries Inc | NASDAQ:LOOP | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.005 | 0.18% | 2.86 | 2.72 | 3.05 | 2.96 | 2.6404 | 2.84 | 10,352 | 00:59:59 |
☒
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT OF 1934
|
|
|
|
For the
quarterly period ended November 30, 2020
|
Loop Industries, Inc.
|
(Exact
name of Registrant as specified in its charter)
|
Nevada
|
|
27-2094706
|
(State
or other jurisdiction of incorporation or
organization)
|
|
(I.R.S.
Employer Identification No.)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common
Stock
|
LOOP
|
Nasdaq
Global Market
|
Large accelerated
filer
|
☐
|
Accelerated
filer
|
☐
|
Non-accelerated
filer
|
☐
|
Smaller reporting
company
|
☒
|
|
|
Emerging growth
company
|
☐
|
|
|
Page No.
|
|
||
|
|
|
4
|
||
5
|
||
13
|
||
14
|
||
|
|
|
|
|
|
15
|
||
16
|
||
17
|
||
17
|
||
17
|
||
17
|
||
18
|
||
|
|
|
|
19
|
Contents
|
|
Page(s)
|
|
|
|
|
F-1
|
|
|
|
|
|
F-2
|
|
|
|
|
|
F-3
|
|
|
|
|
|
F-7
|
|
|
|
|
|
F-8
|
|
Three Months
Ended November 30
|
Nine Months
Ended November 30
|
||
|
2020
|
2019
|
2020
|
2019
|
|
|
|
|
|
Revenue
|
$-
|
$-
|
$-
|
$-
|
|
|
|
|
|
Expenses
|
|
|
|
|
Research and
development (Notes 13 and 14)
|
6,274,283
|
1,278,172
|
10,504,093
|
3,246,246
|
General and
administrative (Note 14)
|
2,724,016
|
1,825,813
|
6,726,339
|
5,447,056
|
Write-down and
impairment of property, plant and equipment (Note 5)
|
5,034,606
|
-
|
5,043,120
|
-
|
Depreciation and
amortization (Notes 5 and 6)
|
104,307
|
219,628
|
654,354
|
562,382
|
Interest and other
financial (income) expenses (Note 17)
|
(41,855)
|
693,027
|
26,016
|
1,817,091
|
Interest
income
|
(20,008)
|
(171,274)
|
(78,394)
|
(363,565)
|
Foreign exchange
loss
|
95,644
|
5,533
|
275,903
|
15,297
|
Total
expenses
|
14,170,993
|
3,850,899
|
23,151,431
|
10,747,492
|
|
|
|
|
|
Net
Loss
|
(14,170,993)
|
(3,850,899)
|
(23,151,431)
|
(10,747,492)
|
|
|
|
|
|
Other comprehensive
income (loss)
|
|
|
|
|
Foreign currency
translation adjustment
|
66,170
|
7,552
|
298,570
|
(30,133)
|
Comprehensive
income (loss)
|
$(14,104,823)
|
$(3,843,347)
|
$(22,852,861)
|
$(10,777,625)
|
|
|
|
|
|
Loss per
share
|
|
|
|
|
Basic and
Diluted
|
$(0.34)
|
$(0.10)
|
$(0.57)
|
$(0.29)
|
|
|
|
|
|
Weighted average
common shares outstanding
|
|
|
|
|
Basic and
Diluted
|
41,715,806
|
39,133,627
|
40,515,885
|
37,404,165
|
|
Three Months
Ended November 30, 2020
|
||||||||||
|
Common stock par
value $0.0001
|
Preferred stock
par value $0.0001
|
|
|
|
|
|
|
|
||
|
Number of
Shares
|
Amount
|
Number of
Shares
|
Amount
|
Additional
Paid-in Capital
|
Additional
Paid-in Capital - Warrants
|
Additional
Paid-in Capital
– Beneficial Conversion Feature
|
Common Stock
Issuable
|
Accumulated
Deficit
|
Accumulated
Other Comprehensive (Loss)
|
Total
Stockholders' Equity
|
Balance, August 31,
2020
|
39,935,210
|
$3,994
|
1
|
$-
|
$84,172,723
|
$9,870,241
|
$-
|
$-
|
$(62,297,485)
|
$(156,049)
|
$31,593,424
|
Issuance of common shares for cash,
net of share issuance costs (Note 12)
|
2,087,000
|
209
|
-
|
-
|
24,996,419
|
-
|
-
|
-
|
-
|
-
|
24,996,628
|
Issuance of shares upon exercise of
warrants (Note 16)
|
190,529
|
19
|
-
|
-
|
2,046,854
|
(394,245)
|
-
|
-
|
-
|
-
|
1,652,628
|
Issuance of shares upon the vesting
of restricted stock units (Notes 12 and 14)
|
200,000
|
20
|
-
|
-
|
(20)
|
-
|
-
|
-
|
-
|
-
|
-
|
Stock options granted for services
(Note 14)
|
-
|
-
|
-
|
-
|
551,720
|
-
|
-
|
-
|
-
|
-
|
551,720
|
Restricted stock units granted for
services (Note 14)
|
-
|
-
|
-
|
-
|
345,274
|
-
|
-
|
-
|
-
|
-
|
345,274
|
Foreign currency
translation
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
66,170
|
66,170
|
Net loss
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(14,170,993)
|
-
|
(14,170,993)
|
Balance,
November 30, 2020
|
42,412,739
|
$4,242
|
1
|
$-
|
$112,112,970
|
$9,475,996
|
$-
|
$-
|
$(76,468,478)
|
$(89,879)
|
$45,034,851
|
|
Nine Months
Ended November 30, 2020
|
||||||||||
|
Common stock par
value $0.0001
|
Preferred stock
par value $0.0001
|
|
|
|
|
|
|
|
||
|
Number of
Shares
|
Amount
|
Number of
Shares
|
Amount
|
Additional
Paid-in
Capital
|
Additional
Paid-in Capital
- Warrants
|
Additional
Paid-in Capital
– Beneficial Conversion Feature
|
Common Stock
Issuable
|
Accumulated
Deficit
|
Accumulated
Other Comprehensive (Loss)
|
Total
Stockholders' Equity
|
Balance, February 29,
2020
|
39,910,774
|
$3,992
|
1
|
$-
|
$82,379,413
|
$9,785,799
|
$-
|
$-
|
$(53,317,047)
|
$(388,449)
|
$38,463,708
|
Issuance of common shares for cash,
net of share issuance costs (Note 12)
|
2,087,000
|
209
|
-
|
-
|
24,996,419
|
-
|
-
|
-
|
-
|
-
|
24,996,628
|
Issuance of shares upon exercise of
warrants (Note 16)
|
190,529
|
19
|
-
|
-
|
2,046,853
|
(394,245)
|
-
|
-
|
-
|
-
|
1,652,627
|
Warrant issued for services (Note
16)
|
-
|
-
|
-
|
-
|
-
|
84,442
|
-
|
-
|
-
|
-
|
84,442
|
Issuance of shares upon the vesting
of restricted stock units (Notes 12 and 14)
|
224,436
|
22
|
-
|
-
|
(22)
|
-
|
-
|
-
|
-
|
-
|
-
|
Stock options granted for services
(Note 14)
|
-
|
-
|
-
|
-
|
1,662,155
|
-
|
-
|
-
|
-
|
-
|
1,662,155
|
Restricted stock units granted for
services (Note 14)
|
-
|
-
|
-
|
-
|
1,028,152
|
-
|
-
|
-
|
-
|
-
|
1,028,152
|
Foreign currency
translation
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
298,570
|
298,570
|
Net loss
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
(23,151,431)
|
-
|
(23,151,431)
|
Balance,
November 30, 2020
|
42,412,739
|
$4,242
|
1
|
$-
|
$112,112,970
|
$9,475,996
|
$-
|
$-
|
$(76,468,478)
|
$(89,879)
|
$45,034,851
|
|
Nine Months
Ended November 30
|
|
|
2020
|
2019
|
Cash Flows from Operating Activities
|
|
|
Net
loss
|
$(23,151,431)
|
$(10,747,492)
|
Adjustments to
reconcile net loss to net cash used in operating
activities:
|
|
|
Depreciation and
amortization (Notes 5 and 6)
|
654,354
|
562,382
|
Stock-based
compensation expense (Note 14)
|
2,774,749
|
2,610,811
|
Write-down and
impairment of property, plant and equipment (Note 5)
|
5,043,120
|
22,985
|
Accretion and
accrued interest (Note 10)
|
56,259
|
1,898,409
|
Loss on
revaluation of warrants
|
-
|
8,483
|
Deferred financing
costs
|
-
|
86,212
|
Gain on conversion
of convertible notes
|
-
|
(232,565)
|
Loss (gain) on
revaluation of foreign exchange contracts
|
(58,945)
|
10,881
|
Changes in
operating assets and liabilities:
|
|
|
Sales tax, tax
credits and other receivables (Note 3)
|
(477,855)
|
(37,536)
|
Prepaid expenses
(Note 4)
|
(1,075,291)
|
52,649
|
Accounts payable
and accrued liabilities (Note 8)
|
1,690,789
|
(1,054,967)
|
Net cash used in
operating activities
|
(14,544,251)
|
(6,819,748)
|
|
|
|
Cash Flows from Investing Activities
|
|
|
Investment in
joint venture (Note 9)
|
(650,000)
|
(850,000)
|
Additions to
property, plant and equipment (Note 5)
|
(1,580,795)
|
(1,647,433)
|
Additions to
intangible assets (Note 6)
|
(155,798)
|
(95,488)
|
Net cash used in
investing activities
|
(2,386,593)
|
(2,592,921)
|
|
|
|
Cash Flows from Financing Activities
|
|
|
Proceeds from sale
of common shares and exercise of warrants, net of share issuance
costs (Note 12)
|
26,649,253
|
39,167,381
|
Repayment of
long-term debt (Note 10)
|
(32,781)
|
(39,506)
|
Net cash provided
from financing activities
|
26,616,472
|
39,127,875
|
|
|
|
Effect of exchange
rate changes
|
210,516
|
(57,105)
|
Net change in cash
and cash equivalents
|
9,896,144
|
29,658,101
|
Cash and cash
equivalents, beginning of period
|
33,717,671
|
5,833,390
|
Cash and cash
equivalents, end of period
|
$43,613,815
|
$35,491,491
|
|
|
|
Supplemental Disclosure of Cash Flow Information:
|
|
|
Income tax
paid
|
$-
|
$-
|
Interest
paid
|
$28,613
|
$45,668
|
Interest
received
|
$78,394
|
$363,565
|
|
November 30,
2020
|
February 29,
2020
|
Sales
tax
|
$669,966
|
$180 971
|
Research and
development tax credits
|
390,885
|
447,843
|
Other
receivables
|
121,256
|
35,730
|
|
$1,182,107
|
$664,544
|
|
November 30,
2020
|
February 29,
2020
|
Deposits on
machinery and equipment
|
$747,250
|
$-
|
Insurance
|
427,013
|
61,891
|
Other prepaid
expenses
|
56,179
|
79,335
|
|
$1,230,442
|
$141,226
|
|
As at November
30, 2020
|
||
|
Cost
|
Accumulated
depreciation, write-down and impairment
|
Net book
value
|
Building
|
$1,912,138
|
$(181,308)
|
$1,730,830
|
Land
|
236,360
|
-
|
236,360
|
Building and land
improvements
|
1,602,766
|
(379,164)
|
1,223,602
|
Machinery and
equipment
|
6,514,252
|
(6,514,252)
|
-
|
Office equipment
and furniture
|
260,220
|
(95,602)
|
164,618
|
Balances, end of
period
|
$10,525,736
|
$(7,170,326)
|
$3,355,410
|
|
As at February 29,
2020
|
||
|
Cost
|
Accumulated
depreciation, write-down and impairment
|
Net book
value
|
Building
|
$1,846,070
|
$(128,911)
|
$1,717,159
|
Land
|
264,868
|
-
|
264,868
|
Building and land
improvements
|
733,884
|
(214,068)
|
519,816
|
Machinery and
equipment
|
6,085,195
|
(1,426,465)
|
4,658,730
|
Office equipment
and furniture
|
162,466
|
(62,785)
|
99,681
|
Balances, end of
period
|
$9,092,483
|
$(1,832,229)
|
$7,260,254
|
|
November 30,
2020
|
February 29,
2020
|
|
|
|
Intangible assets,
at cost - beginning of period
|
$225,174
|
$127,672
|
Intangible assets,
accumulated depreciation – beginning of period
|
(22,311)
|
-
|
|
202,863
|
127,672
|
|
|
|
Additions in the
period
|
452,758
|
99,972
|
Amortization of
intangibles
|
(30,165)
|
(22,631)
|
Foreign exchange
effect – increase (decrease)
|
6,133
|
(2,150)
|
|
$631,589
|
$202,863
|
|
November 30,
2020
|
February 29,
2020
|
Trade accounts
payable
|
$1,514,881
|
$814,081
|
Accrued engineering
fees
|
686,061
|
-
|
Accrued employee
compensation and payroll taxes
|
678,925
|
873,242
|
Accrued
professional fees
|
676,153
|
133,038
|
Accrued cost of
machinery and equipment
|
415,522
|
92,126
|
Other accrued
liabilities
|
116,605
|
170,211
|
|
$4,088,147
|
$2,082,698
|
|
November 30,
2020
|
February 29,
2020
|
Investissement
Québec financing facility:
|
|
|
Principal
amount
|
$1,703,998
|
$1,645,122
|
Unamortized
discount
|
(272,036)
|
(289,852)
|
Accrued
interest
|
31,549
|
958
|
Total
Investissement Québec financing facility
|
1,463,511
|
1,356,228
|
Term
loan
|
|
|
Principal
amount
|
926,855
|
933,924
|
Less: current
portion
|
(53,992)
|
(52,126)
|
Total term loan,
net of current portion
|
872,863
|
881,798
|
Long-term debt, net
of current portion
|
$2,336,374
|
$2,238,026
|
Years
ending
|
Amount
|
February 28,
2021
|
$13,498
|
February 28,
2022
|
53,992
|
February 28,
2023
|
53,992
|
February 29,
2024
|
297,416
|
February 28,
2025
|
297,416
|
Thereafter
|
1,901,043
|
Total
|
$2,617,355
|
For
the period ended November 30, 2020
|
Number of
shares
|
Amount
|
Balance, February
29, 2020
|
39,910,774
|
$3,992
|
Issuance of shares
for cash
|
2,087,000
|
209
|
Issuance of shares
upon the exercise of warrants
|
190,529
|
19
|
Issuance of shares
upon settlement of restricted stock units
|
224,436
|
22
|
Balance, November
30, 2020
|
42,412,739
|
$4,242
|
For
the period ended November 30, 2019
|
Number of
shares
|
Amount
|
Balance, February
28, 2019
|
33,805,706
|
$3,381
|
Issuance of shares
for cash
|
4,693,567
|
469
|
Issuance of shares
upon vesting of restricted stock units
|
243,932
|
24
|
Issuance of shares
upon the cashless exercise of stock options
|
4,565
|
1
|
Issuance of shares
upon the exercise of warrants
|
15,432
|
1
|
Issuance of shares
upon settlement of legal matter
|
150,000
|
15
|
Issuance of shares
upon conversion of Convertible notes
|
319,326
|
32
|
Balance, November
30, 2019
|
39,232,528
|
$3,923
|
(i)
|
On
September 23, 2020 and October 1, 2020, the Company sold 1,880,000
and 207,000 shares, respectively of its common stock at an offering
price of $12.75 per share in a registered direct offering, for
total gross proceeds of $26,609,250.
|
(ii)
|
The
company issued 192,529 shares of its common stock upon the exercise
of warrants.
|
(iii)
|
On
October 15, 2020, the Company issued 200,000 shares of common stock
to settle restricted stock units related to the President and Chief
Executive Officer.
|
(iv)
|
The
Company issued 24,436 shares of its common stock to settle
restricted stock units that vested in the period.
|
(i)
|
On
March 1, 2019, the Company sold 600,000 shares of its common stock
at an offering price of $8.55 per share in a registered direct
offering, for gross proceeds of $5,130,000.
|
(ii)
|
On
March 8, 2019 and March 11, 2019, the Company issued 150,000 shares
of its common stock in settlement of a legal matter.
|
(iii)
|
On
April 9, 2019, the Company converted Convertible notes with a face
value of $2,650,000 plus accrued interest of $80,241 at a
conversion price of $8.55, into 319,326 common shares.
|
(iv)
|
On June
14, 2019, the Company sold 4,093,567 shares of its common stock at
an offering price of $8.55 per share in a registered direct
offering, for gross proceeds of $35,000,000.
|
(v)
|
On June
21, 2019, the Company issued 7,043 shares of common stock upon the
vesting of restricted stock units related to an
employee.
|
(vi)
|
On July
2, 2019 and July 3, 2019, the Company issued 23,547 shares of
common stock upon the vesting of restricted stock units related to
current and former Directors.
|
(vii)
|
On July
12, 2019, the Company issued 4,565 shares of common stock upon the
cashless exercise of stock options related to an
employee.
|
(viii)
|
On July
15, 2019, the Company issued 13,342 shares of common stock upon the
vesting of restricted stock units related to a former
Director.
|
(ix)
|
On July
17, 2019, the Company issued 15,432 shares of common stock upon the
exercise of warrants.
|
(x)
|
On
October 15, 2019, the Company issued 200,000 shares of common stock
to settle restricted stock units related to the President and Chief
Executive Officer.
|
|
November 30,
2020
|
November 30,
2019
|
External
engineering
|
$2,224,910
|
$33,131
|
Machinery and
equipment expenditures
|
2,325,540
|
-
|
Employee
compensation
|
1,214,434
|
973,679
|
Pilot plant
operating expenses
|
399,031
|
166,753
|
Other
|
110,368
|
104,610
|
|
$6,274,283
|
$1,278,173
|
|
November 30,
2020
|
November 30,
2019
|
External
engineering
|
$3,241,959
|
$83,462
|
Employee
compensation
|
3,094,151
|
2,453,743
|
Machinery and
equipment expenditures
|
2,325,540
|
-
|
Pilot plant
operating expenses
|
1,537,271
|
456,942
|
Other
|
305,172
|
252,099
|
|
$10,504,093
|
$3,246,246
|
|
2020
|
2019
|
Exercise
price
|
$8.78
|
$-
|
Risk-free interest
rate
|
1.05%
|
-
|
Expected dividend
yield
|
0.00%
|
-
|
Expected
volatility
|
75.95%
|
-
|
Expected
life
|
7.5
years
|
-
|
|
Three Months Ended
November 30
|
Nine Months Ended
November 30
|
||
|
2020
|
2019
|
2020
|
2019
|
Interest
on long-term debt
|
$19,185
|
$14,778
|
$57,917
|
$41,840
|
Interest
on convertible notes
|
-
|
98,000
|
-
|
313,433
|
Accretion
expense
|
9,387
|
549,090
|
27,044
|
1,584,977
|
Amortization
of deferred finance costs
|
-
|
19,885
|
-
|
86,212
|
Loss
(gain) on revaluation of foreign exchange contracts
|
(70,427)
|
10,881
|
(58,945)
|
10,881
|
Revaluation
of warrants
|
-
|
-
|
-
|
8,483
|
Gain on
conversion of November 2018 Notes
|
-
|
-
|
-
|
(232,565)
|
Other
|
-
|
393
|
-
|
3,830
|
|
$(41,855)
|
$693,027
|
$26,016
|
$1,817,091
|
|
Three Months
Ended November 30
|
||
|
2020
|
2019
|
$
Change
|
Revenues
|
$-
|
$-
|
$-
|
|
|
|
|
Operating
expenses
|
|
|
|
Research and
development
|
|
|
|
Stock-based
compensation
|
350,393
|
311,353
|
39,040
|
Other
research and development
|
5,923,890
|
966,819
|
4,957,071
|
Total
research and development
|
6,274,283
|
1,278,172
|
4,996,111
|
|
|
|
|
General and
administrative
|
|
|
|
Stock-based
compensation
|
546,601
|
565,440
|
(18,839)
|
Other
general and administrative
|
2,177,415
|
1,260,373
|
917,014
|
Total
general and administrative
|
2,724,016
|
1,825,813
|
898,203
|
|
|
|
|
Write-down and
impairment of property, plant and equipment
|
5.034,606
|
-
|
5,034,606
|
Depreciation and
amortization
|
104,307
|
219,628
|
(115,321)
|
Interest and other
financial (income) expenses
|
(41,855)
|
693,027
|
(734,882)
|
Interest
income
|
(20,008)
|
(171,274)
|
151,266
|
Foreign exchange
loss
|
95,644
|
5,533
|
90,111
|
Total
operating expenses
|
14,170,993
|
3,850,899
|
10,320,094
|
Net
loss
|
$(14,170,993)
|
$(3,850,899)
|
$(10,320,094)
|
|
Nine Months Ended
November 30
|
|
|
2020
|
2019
|
Net cash used in
operating activities
|
$(14,544,251)
|
$(6,819,748)
|
Net cash used in
investing activities
|
(2,386,593)
|
(2,592,921)
|
Net cash provided
(used) by financing activities
|
26,616,472
|
39,127,875
|
Effect of exchange
rate changes on cash and cash equivalents
|
210,516
|
(57,105)
|
Net increase
(decrease) in cash and cash equivalents
|
$9,896,144
|
$29,658,101
|
|
|
|
|
Incorporated by Reference
|
|
|
||||
Number
|
|
Description
|
|
Form
|
|
File No.
|
|
Filing Date
|
|
Exhibit No.
|
|
Termination
of a Material Definitive Agreement, by and between Loop Industries,
Inc. and Coca-Cola Cross Enterprise Procurement Group.
|
|
8-K
|
|
001-38301
|
|
4-Nov-20
|
|
|
|
|
Amendment
to Securities Purchase Agreement dated June 14, 2019 between Loop
Industries, Inc. and the Purchaser identified therein.
|
|
8-K
|
|
001-38301
|
|
14-Jun-19
|
|
10.1
|
|
|
Employment
Agreement, dated August 26, 2020, by and between Loop Canada Inc.
and Sheila Morin
|
|
10-Q
|
|
000-54768
|
|
10-July-20
|
|
10.1
|
|
10.2
|
|
Know-how
and Engineering Agreement, dated September 2, 2020, by and between
Loop Canada Inc. and Chemtex Global Corporation
|
|
10-Q
|
|
000-54768
|
|
10-July-20
|
|
10.2
|
10.3
|
|
Enhanced
Recycling Partnership Agreement, dated September 10, 2020, by and
between Loop Industries, Inc. and Suez Groupe
|
|
10-Q
|
|
000-54768
|
|
10-July-20
|
|
10.3
|
24.1
|
|
Power
of Attorney (contained on signature page to the previously filed
Annual Report on Form 10-K)
|
|
10-K
|
|
000-54768
|
|
05-May-19
|
|
24.1
|
|
Certification
of Principal Executive Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
|
|
Filed
herewith
|
|
|
|
|
|
|
Certification
of Principal Financial Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
|
|
Filed
herewith
|
|
|
|
|
|
|
Certification
of Principal Executive Officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
|
|
|
|
Furnished
herewith
|
|
|
|
|
|
|
Certification
of Principal Financial Officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
|
|
|
|
Furnished
herewith
|
|
|
|
|
|
101.INS
|
|
XBRL
Instance Document
|
|
|
|
Filed
herewith
|
|
|
|
|
101.SCH
|
|
XBRL
Taxonomy Extension Schema Document
|
|
|
|
Filed
herewith
|
|
|
|
|
101.CAL
|
|
XBRL
Taxonomy Extension Calculation Linkbase Document
|
|
|
|
Filed
herewith
|
|
|
|
|
101.DEF
|
|
XBRL
Taxonomy Extension Definition Linkbase Document
|
|
|
|
Filed
herewith
|
|
|
|
|
101.LAB
|
|
XBRL
Taxonomy Extension Label Linkbase Document
|
|
|
|
Filed
herewith
|
|
|
|
|
101.PRE
|
|
XBRL
Taxonomy Extension Presentation Linkbase Document
|
|
|
|
Filed
herewith
|
|
|
|
|
Date:
January 14, 2021
|
By:
|
/s/ Daniel Solomita
|
|
|
Name:
|
Daniel
Solomita
|
|
|
Title:
|
President
and Chief Executive Officer, and Director (Principal Executive
Officer)
|
|
|
|
|
|
Date:
January 14, 2021
|
By:
|
/s/ Nelson Gentiletti
|
|
|
Name:
|
Nelson
Gentiletti
|
|
|
Title:
|
Chief
Financial Officer and Treasurer (Principal Accounting Officer and
Principal Financial Officer)
|
|
|
|
|
|
1 Year Loop Industries Chart |
1 Month Loop Industries Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions